Title: AMI/ACS Dx: Old EKG
1AMI/ACS Dx Old EKG
- When comparing to an old EKG, the old EKG should
not be one done in the ED at the time of the
acute presentation for AMI/ACS - The goal is to establish no change as compared to
baseline, non-ischemia EKG, eg LVH with strain
pattern
2EKG Diagnosis LVH with Strain Pattern
- LVH criteria, ST-T wave changes
3Diagnosis ECG Monitoring
- Dysrhythmias
- Bradycardia
- Heart blocks
- Malignant ventricular ectopy
- Ventricular Fibrillation
4Bifascicular Block
- RBBB Opposite T waves normal
5Non-sustained VT in AMI
6Non-sustained VT in AMI
7AMI/ACS DiagnosisCardiac Enzymes
8AMI/ACS Lab Evaluation
Marker Elevation Peak Duration
Myoglobin 1-4 h 6 h 24 h
Troponin I 3-12 h 18 h 5-10 days
Troponin T 3-12 h 12 h 5-14 days
CK-MB 3-12 h 18-24 h 2 days
9Cardiac Enzymes CPK-MB
- CPK-MB
- Sensitive and specific
- Limited potential for early diagnosis??
- Two hour change in CK-MB may be accurate to
predict ACS
10Cardiac Enzymes Myoglobin
- Myoglobin
- Sensitive but not specific
- Not used to rule out clinically
- Peaks earlier than CPK
- Limited utility given ability to use CK-MB and
troponin
11Cardiac Enzymes Troponins
- Troponins true cardiac markers
- Touted to be highly specific
- More sensitive than CPK-MB at detecting small
infarcts - Elevation predicts ? mortality and complications
- Troponin T less specific than troponin I
12Cardiac Enzymes Troponins
- Troponins
- Can troponin be positive without ACS?
- What is the significance of isolated troponin
elevation with neg EKG? - Cannot overlook higher complication rate if
troponin positive
13AMI/ACS DiagnosisOther Acute Tests
14AMI/ACS Diagnosis CXR
- CM, CHF
- Other causes of chest pain
- Pneumothorax, rib fractures
- Pneumonia
- Aortic dissection
- Carcinoma
15AMI/ACS Diagnosis CXR
16AMI/ACS Diagnosis Echocardiography
- What are the indications for echocardiography in
the ED? - How might this data alter the acute management of
an STEMI patient?
17AMI/ACS Diagnosis Echocardiography
- Uncertain ACS diagnosis
- Uncertain need for acute PCI
- LV dysfunction suggests more gravely ill AMI
patient - Valvular dysfunction
18AMI/ACS Diagnosis Echocardiography
- Sensitive in detecting regional wall motion
abnormalities - Cannot differentiate between ischemia, AMI, or
old MI - Can detect valve stenosis, regurgitation,
insufficiency
19AMI/ACS Diagnosis Echocardiography
20AMI/ACS Diagnosis Stress Testing
- Measures inducible ischemia
- Must rule out AMI/ACS first
- Physical, process limitations
- Stress thallium may be needed
- Accuracy, utility can vary
- Part of a chest pain protocol
21AMI/ACS Diagnosis Stress Testing
- Persantine stress test
- In general, thallium clears more slowly from
regions supplied by stenotic vessels than from
normal myocardial regions. Areas of significant
hypoperfusion will have very slow clearance and
may even accumulate thallium.
22AMI/ACS Diagnosis Sestamibi (Cardiolyte) Scanning
- Technetium
- Measures focal ischemia
- Pain for at least 1 hr or ongoing
- Resolution within 30 min only
- Poor perfusion, no uptake
- May lead to early catheterization
- Part of a chest pain protocol
23AMI/ACS Diagnosis Sestamibi (Cardiolyte) Scanning
- Myoview ( technetium Tc-99m tetrofosmin )
- A cardiac imaging agent, is useful in the
diagnosis and localization of regions of
reversible myocardial ischemia in the presence or
absence of infarction under exercise and rest
conditions.
24AMI/ACS DiagnosisChest Pain Protocols
25AMI/ACS Diagnosis Chest Pain Protocols
- Low risk population
- Serial EKGs
- Serial cardiac enzymes
- Provocative testing as needed
- Detects AMI, ACS
- Identify uncomplicated patients
26AMI/ACS Diagnosis Chest Pain Protocols
- The Erlanger chest pain evaluation protocol a
one-year experience with serial 12-lead ECG
monitoring, two-hour delta serum marker
measurements, and selective nuclear stress
testing to identify and exclude acute coronary
syndromes. - Fesmire F Ann Emer Med 2002
- CONCLUSION An accelerated chest pain evaluation
strategy consisting of SECG, 2-hour delta serum
marker measurements, and selective nuclear stress
testing in conjunction with physician judgment
identifies and excludes MI and 30-day ACS during
the initial evaluation of patients with chest
pain.
27(No Transcript)
28(No Transcript)
29(No Transcript)
30AMI/ACS Diagnosis Chest Pain Protocols
- Delta creatine kinase-MB outperforms myoglobin at
two hours during the emergency department
identification and exclusion of troponin positive
non-ST-segment elevation acute coronary
syndromes. - Fesmire F Ann Emer Med 2004
- CONCLUSION A 2-hour delta CK-MB level
outperforms myoglobin level in the early
identification and exclusion of acute myocardial
infarction in non-ST-segment elevation chest pain
patients. This finding suggests that myoglobin
may no longer be the optimal early marker of
acute myocardial infarction when troponins are
used as the criterion standard.
31(No Transcript)
32(No Transcript)
33AMI/ACS DiagnosisGuidelines
34 AMI/ACS Rx Guidelines
- What guidelines guide AMI Rx?
- How are these guidelines derived? How are they
stated
35 ACEP AMI/ACS Guidelines
- Ann Emer Med, 2000
- Standards, guidelines, options
- Criteria emergent reperfusion Rx
- PTCA within 120 minutes
- Options for serial enzymes
36AMI/ACS Diagnosis Clinical Guidelines
- Low risk population
- Serial EKGs
- Serial cardiac enzymes
- Provocative testing as needed
- Detects AMI, ACS
- Identify uncomplicated patients
37(No Transcript)
38(No Transcript)
39(No Transcript)
40(No Transcript)
41(No Transcript)
42(No Transcript)
43AMI/ACS Diagnosis Conclusions
- Important clinical disease state
- Risk stratification key
- Diagnosis can be made
- Most tests acutely available
- A protocol assists in diagnosis
44AMI/ACS DiagnosisQuestions?
- www.acc.org or www.americanheart.org
- www.acep.org
- www.guidelines.gov
- PDF file allows for optimal printing
- edsloan_at_uic.edu (312) 413-7490
ami acs icep part 1 modified 2007